Identification of Substituted Naphthotriazolediones as Novel Tryptophan 2,3-Dioxygenase (TDO) Inhibitors through Structure-Based Virtual Screening

被引:50
作者
Wu, Jian-Sung [1 ]
Lin, Shu-Yu [1 ]
Liao, Fang-Yu [1 ]
Hsiao, Wen-Chi [1 ]
Lee, Lung-Chun [1 ]
Peng, Yi-Hui [1 ]
Hsieh, Chia-Ling [1 ]
Wu, Mine-Hsine [1 ]
Song, Jen-Shin [1 ]
Yueh, Andrew [1 ]
Chen, Chun-Hwa [1 ]
Yeh, Shiu-Hwa [1 ]
Liu, Chia-Yeh [2 ]
Lin, Shu-Yi [2 ]
Yeh, Teng-Kuang [1 ]
Hsu, John T. -A. [1 ]
Shih, Chuan [1 ]
Ueng, Shau-Hua [1 ]
Hung, Ming-Shiu [1 ]
Wu, Su-Ying [1 ]
机构
[1] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan Town 350, Miaoli County, Taiwan
[2] Natl Hlth Res Inst, Inst Biomed Engn & Nanomed, Zhunan Town 350, Miaoli County, Taiwan
关键词
GROWTH-FACTOR RECEPTOR; PROTEIN-TYROSINE PHOSPHATASES; INDOLEAMINE 2,3-DIOXYGENASE; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURES; SUBSTRATE RECOGNITION; CATALYTIC MECHANISM; DISCOVERY; ASSAY; LIGAND;
D O I
10.1021/acs.jmedchem.5b00921
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A structure-based virtual screening strategy, comprising homology modeling, ligand support binding site optimization, virtual screening, and structure clustering analysis, was developed and used to identify novel tryptophan 2,3-dioxygenase (TDO) inhibitors. Compound 1 (IC50 = 711 nM), selected by virtual screening, showed inhibitory activity toward TDO and was subjected to structural modifications and molecular docking studies. This resulted in the identification of a potent TDO selective inhibitor (11e, IC50 = 30 nM), making it a potential compound for further investigation as a cancer therapeutic and other TDO-related targeted therapy.
引用
收藏
页码:7807 / 7819
页数:13
相关论文
共 50 条
  • [1] Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening
    Sari, Suat
    Tomek, Petr
    Leung, Euphemia
    Reynisson, Johannes
    MOLECULES, 2019, 24 (23):
  • [2] Aminoisoxazoles as Potent Inhibitors of Tryptophan 2,3-Dioxygenase 2 (TDO2)
    Pei, Zhonghua
    Mendonca, Rohan
    Gazzard, Lewis
    Pastor, Richard
    Goon, Leanne
    Gustafson, Amy
    VanderPorten, Erica
    Hatzivassiliou, Georgia
    Dement, Kevin
    Cass, Robert
    Yuen, Po-wai
    Zhang, Yamin
    Wu, Guosheng
    Lin, Xingyu
    Liu, Yichin
    Sellers, Benjamin D.
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (05): : 417 - 421
  • [3] N-Benzyl/Aryl Substituted Tryptanthrin as Dual Inhibitors of Indoleamine 2,3-Dioxygenase and Tryptophan 2,3-Dioxygenase
    Yang, Dan
    Zhang, Shengnan
    Fang, Xin
    Guo, Leilei
    Hu, Nan
    Guo, Zhanling
    Li, Xishuai
    Yang, Shuangshuang
    He, Jin Chao
    Kuang, Chunxiang
    Yang, Qing
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (20) : 9161 - 9174
  • [4] Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase
    Yoshioka, Saeko
    Ikeda, Tomonori
    Fukuchi, Sogo
    Kawai, Yurika
    Ohta, Katsumi
    Murakami, Hisashi
    Ogo, Naohisa
    Muraoka, Daisuke
    Takikawa, Osamu
    Asai, Akira
    INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH, 2022, 15
  • [5] Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase
    Li, Yuanyuan
    Zhang, Shengnan
    Wang, Rong
    Cui, Menghan
    Liu, Wei
    Yang, Qing
    Kuang, Chunxiang
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (11)
  • [6] Discovery of indoleamine 2,3-dioxygenase inhibitors using machine learning based virtual screening
    Zhang, Hongao
    Liu, Wei
    Liu, Zhihong
    Ju, Yingchen
    Xu, Mengyang
    Zhang, Yue
    Wu, Xinyu
    Gu, Qiong
    Wang, Zhong
    Xu, Jun
    MEDCHEMCOMM, 2018, 9 (06) : 937 - 945
  • [7] Evaluation and comparison of the commonly used bioassays of human indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO)
    Zhang, Shengnan
    Guo, Leilei
    Yang, Dan
    Xing, Zikang
    Li, Weirui
    Kuang, Chunxiang
    Yang, Qing
    BIOORGANIC CHEMISTRY, 2020, 104
  • [8] Identification of novel Trypanosoma cruzi prolyl oligopeptidase inhibitors by structure-based virtual screening
    de Almeida, Hugo
    Leroux, Vincent
    Motta, Flavia Nader
    Grellier, Philippe
    Maigret, Bernard
    Santana, Jaime M.
    Dourado Bastos, Izabela Marques
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2016, 30 (12) : 1165 - 1174
  • [9] Identification of novel BRAF kinase inhibitors with structure-based virtual screening
    Park, Hwangseo
    Choi, Hwanho
    Hong, Seunghee
    Hong, Sungwoo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (19) : 5753 - 5756
  • [10] Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2
    Bakmiwewa, Supun M.
    Fatokun, Amos A.
    Anh Tran
    Payne, Richard J.
    Hunt, Nicholas H.
    Ball, Helen J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (24) : 7641 - 7646